NCT05010005 2026-04-09A Study of Ruxolitinib and Duvelisib in People With LymphomaMemorial Sloan Kettering Cancer CenterPhase 1 Recruiting70 enrolled
NCT05592015 2026-02-10Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic LeukemiaOhio State University Comprehensive Cancer CenterPhase 2 Recruiting30 enrolled